-
Mashup Score: 0FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma - 2 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options - 2 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Clinical Outcomes and Racial Disparities in Metastatic Hormone‐Sensitive Prostate Cancer in the Era of Novel Treatment Options #ProstateCancer #RacialDisparities #UpfrontTherapy #Abiraterone #Docetaxel https://t.co/aIqHmI9cy6 https://t.co/zFiHi5ZwYy
-
-
Mashup Score: 0
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Patient Burden with Current Surveillance Paradigm and Factors Associated with Interest in Altered Surveillance for Early Stage HPV‐Related Oropharyngeal Cancer #Surveillance #OropharyngealCancer #HumanPapillomavirus #Survivorship #HPV https://t.co/w7vRXKKN0c https://t.co/tJJrJ7pUaZ
-
-
Mashup Score: 0
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy‐Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions #Epoetin #Biosimilars #Interchangeable #Substitution #Guidelines https://t.co/UxnXp4DjAc https://t.co/RzDIY3YBw0
-
-
Mashup Score: 4Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer - 2 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer #BreastCancer #DoseDenseChemotherapy #Premedication #Hypersensitivity #Paclitaxel https://t.co/ApXbpD8SD2 https://t.co/YWjSReuj86
-
-
Mashup Score: 0
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Real‐World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR‐Merkel #MerkelCellCarcinoma #Avelumab #RealWorldOutcomes #Immunotherapy #CommunityOncology https://t.co/z74NGyoOBb https://t.co/s7KoeLgPJK
-
-
Mashup Score: 5
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Outcomes and Prognostic Factors of Patients with Metastatic Colorectal Cancer Who Underwent Pulmonary Metastasectomy with Curative Intent: A Brazilian Experience #ColorectalNeoplasms #Metastasectomy #Keratin20 #Prognosis #Biomarkers https://t.co/HwID6p4hN6 https://t.co/608jlAc9gq
-
-
Mashup Score: 0
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Oncs, Latest HeadlinesTweet-
P.S. I had never heard the term "dirty targeted therapy" before! I will read the reference and wonder if @VivekSubbiah calls it dirty too. https://t.co/vRD19vXxZk
-
-
Mashup Score: 13The Oncologist - 2 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Latest Headlines, Oncologists1Tweet-
Thx @drdonsdizon for chatting w me and @OncJournal for publishing our convo! And thx @UCSFCancer for creating the #hospitalbasedoncology #hbo program and letting me be part of it. 🙏 @HemOncFellows @ASCO @UCSFDOM @UCSFDHM @danielkwonmd @HemoncUcsf https://t.co/8H6cfIyByp
-
-
Mashup Score: 0Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011–2017 - 2 year(s) ago
The Oncologist is committed to helping physicians excel in the constantly changing fields of oncology and hematology through the publication of timely reviews, original studies, and commentaries on important developments.
Source: The OncologistCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Prescription Opioids Dispensed to Patients with Cancer with Bone Metastasis: 2011–2017 https://t.co/amKFjxapxq https://t.co/JDMpOP2N2N
-
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma #DiffuseLargeBCellLymphoma #NonHodgkinLymphoma #TransformedLymphoma #Selinexor #Lymphoma https://t.co/sjYQ48wYWZ https://t.co/5pHBYB1DOR